301 related articles for article (PubMed ID: 17674071)
1. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation.
Hashimoto T; Shigetomi M; Ohno T; Matsunaga T; Muramatsu K; Tanaka H; Sugiyama T; Taguchi T
Calcif Tissue Int; 2007 Sep; 81(3):232-9. PubMed ID: 17674071
[TBL] [Abstract][Full Text] [Related]
2. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
[TBL] [Abstract][Full Text] [Related]
4. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.
Andreassen TT; Fledelius C; Ejersted C; Oxlund H
Acta Orthop Scand; 2001 Jun; 72(3):304-7. PubMed ID: 11480610
[TBL] [Abstract][Full Text] [Related]
5. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
[TBL] [Abstract][Full Text] [Related]
6. Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48.
Rozen N; Lewinson D; Bick T; Jacob ZC; Stein H; Soudry M
Bone; 2007 Sep; 41(3):437-45. PubMed ID: 17599848
[TBL] [Abstract][Full Text] [Related]
7. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures.
Andreassen TT; Ejersted C; Oxlund H
J Bone Miner Res; 1999 Jun; 14(6):960-8. PubMed ID: 10352105
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model.
Abe Y; Takahata M; Ito M; Irie K; Abumi K; Minami A
Bone; 2007 Nov; 41(5):775-85. PubMed ID: 17707711
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
10. Effects of cerivastatin on vascularized allogenic bone transplantation in rats treated with cyclosporine A.
Ohno T; Shigetomi M; Ihara K; Ikeda K; Tsubone T; Matsunaga T; Sugiyama T; Kawai S
Calcif Tissue Int; 2003 Jan; 72(1):50-6. PubMed ID: 12384812
[TBL] [Abstract][Full Text] [Related]
11. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats.
Turner RT; Evans GL; Lotinun S; Lapke PD; Iwaniec UT; Morey-Holton E
J Bone Miner Res; 2007 Jan; 22(1):64-71. PubMed ID: 17042715
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).
Nakajima A; Shimoji N; Shiomi K; Shimizu S; Moriya H; Einhorn TA; Yamazaki M
J Bone Miner Res; 2002 Nov; 17(11):2038-47. PubMed ID: 12412812
[TBL] [Abstract][Full Text] [Related]
13. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase.
Andreassen TT; Willick GE; Morley P; Whitfield JF
Calcif Tissue Int; 2004 Apr; 74(4):351-6. PubMed ID: 15255072
[TBL] [Abstract][Full Text] [Related]
14. Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat.
Mitlak BH; Burdette-Miller P; Schoenfeld D; Neer RM
J Bone Miner Res; 1996 Apr; 11(4):430-9. PubMed ID: 8992873
[TBL] [Abstract][Full Text] [Related]
15. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.
Rowshan HH; Parham MA; Baur DA; McEntee RD; Cauley E; Carriere DT; Wood JC; Demsar WJ; Pizarro JM
J Oral Maxillofac Surg; 2010 Feb; 68(2):260-7. PubMed ID: 20116693
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum.
Oxlund H; Ejersted C; Andreassen TT; Tørring O; Nilsson MH
Calcif Tissue Int; 1993 Dec; 53(6):394-9. PubMed ID: 8293353
[TBL] [Abstract][Full Text] [Related]
17. Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures.
Tägil M; McDonald MM; Morse A; Peacock L; Mikulec K; Amanat N; Godfrey C; Little DG
Bone; 2010 Mar; 46(3):852-9. PubMed ID: 19922821
[TBL] [Abstract][Full Text] [Related]
18. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
Compston JE
Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
[TBL] [Abstract][Full Text] [Related]
20. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
